Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Image Competition 2024 Results, Part 1—Best Overall

Rachel Guess, MD  |  Issue: December 2024  |  December 10, 2024

For the 2024 Image Competition, the ACR sought images representing a diverse range of patients with educational or remarkable manifestations of pediatric rheumatic diseases, including autoimmune, inflammatory, infectious and malignant drivers of pediatric rheumatic disease. Here, we showcase the images selected as Best Overall.

Figure 1. Click to enlarge.

Cavitary Lung Nodules with Sinus & Skin Disease in Pediatric ANCA-Associated Vasculitis

These images are of a 14-year-old boy diagnosed with PR3+ granulomatosis with polyangiitis. His disease manifested with bilateral iritis, vasculitic rash with chronic ulceration, sinus disease, arthritis, proteinuria and hemoptysis, with alveolar hemorrhage and nodules on both lungs.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

From top: Figure 1 shows the evolution of very large pulmonary cavitary nodules, with computed tomography (CT) images of the chest taken at diagnosis, at disease flare, at failure of remission induction and at repeat induction. Figure 2 shows the sinus disease with edematous turbinates with copious discharge. Figure 3 is the CT scan of the sinuses, demonstrating perforation of the nasal septum and polypoid changes. Figure 4 depicts a chronic skin ulcer on the foot.

Figure 2. Click to enlarge.

Patient update: This patient underwent repeat induction therapy in January 2024 and is currently considered in remission. He was recently tapered off systemic corticosteroids after prolonged use due to disease activity. He is on maintenance therapy consisting of 500 mg of obinutuzumab administered every six months, 30 mg of avacopan twice daily and an 800 mg/160 mg tablet of sulfamethoxazole-trimethoprim once daily. He receives intravenous immunoglobulin every four weeks for acquired hypogammaglobulinemia secondary to B cell-depleting therapy. He has been cleared to return to activity and sports as tolerated, with rescue albuterol inhaler use as needed.

Figure 3. Click to enlarge.

Learn More

ANCA-associated vasculitis and related conditions are a developing area of understanding in rheumatology. This rare autoimmune disease causes necrotizing inflammation of the small blood vessels. It has three subtypes: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPO) and eosinophilic granulomatosis with polyangiitis (EGPA). The condition classically affects the lungs and kidneys, although it can affect many other organs, as was the case with this patient.

Figure 4. Click to enlarge.

In children, ANCA-associated vasculitis is nearly always fatal without medical intervention and can cause significant morbidity related to organ damage. In most cases, strong immunosuppressive treatment is indicated to put a patient into remission, although relapses remain frequent. To learn about recent advances in diagnostic tools, assessment methods and treatment options for the small-vessel vasculitides, read our article, “2024 Research Updates in ANCA-Associated & IgA Vasculitis.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:ANCA-Associated Vasculitisimage case reportImage CompetitionPediatric

Related Articles

    Top Research in ANCA-Associated Vasculitis Presented at ACR Convergence 2023

    November 21, 2023

    SAN DIEGO—Vasculitis expert and former editor of The Rheumatologist, Dr. Philip Seo gives us his picks for the 10 most important abstracts in ANCA-associated vasculitis to come out of ACR Convergence 2023.

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

    Wegener’s Granulomatosis Treatment Today

    October 1, 2008

    WG has an evolving prognosis and treatment course

    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences